Labcorp director converts 897 RSUs into shares

Labcorp Holdings Inc. director Paul Rothman reported acquiring shares through the vesting of equity awards.

Rhea-AI Filing Summary

Labcorp Holdings Inc. director Paul Rothman reported acquiring shares through the vesting of equity awards. On February 11, 2026, he exercised 897 Restricted Stock Units, which converted into 897 shares of Labcorp common stock at an exercise price of $0 per share.

Following this transaction, Rothman directly owned 2,571 shares of Labcorp common stock and held 773 Restricted Stock Units, which represent rights to receive the same number of common shares. The filing reflects routine equity compensation vesting rather than an open‑market purchase or sale.

Insider Trade Summary

897 shares exercised/converted

Exercise 2 txns

Insider Rothman Paul

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit	897	$0.00	$0.00
Exercise	Common Stock	897	$0.00	$0.00

Holdings After Transaction: Restricted Stock Unit — 773 contracts (Direct); Common Stock — 2,571 shares (Direct)

Footnotes (3)

1. F1. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
2. F2. The Restricted Stock Units vested fully on February 11, 2026.
3. F3. This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Labcorp (LH) director Paul Rothman report?

Paul Rothman reported the vesting and exercise of 897 Restricted Stock Units into 897 shares of Labcorp common stock. The transaction occurred on February 11, 2026 and reflects equity compensation, not an open-market buy or sell.

How many Labcorp (LH) shares does Paul Rothman own after this Form 4?

After the reported transaction, Paul Rothman directly owned 2,571 shares of Labcorp common stock. In addition, he held 773 Restricted Stock Units, which represent the right to receive an equal number of Labcorp common shares in the future.

What was the price for the Restricted Stock Unit conversion reported for Labcorp (LH)?

The 897 Restricted Stock Units converted into 897 Labcorp common shares at an exercise price of $0 per share. This indicates the shares were received as part of equity compensation rather than purchased in the open market for cash.

What do the Restricted Stock Units in the Labcorp (LH) Form 4 represent?

Each Restricted Stock Unit represents a contingent right to receive one share of Labcorp Holdings Inc. common stock. These units typically vest over time, and once vested, they convert into common shares, as occurred with the 897 units on February 11, 2026.

When did the Labcorp (LH) Restricted Stock Units held by Paul Rothman vest?

The Restricted Stock Units vested fully on February 11, 2026. On that same date, 897 vested units were exercised and converted into 897 Labcorp common shares, as disclosed in the Form 4 insider transaction report.

How many Labcorp (LH) Restricted Stock Units does Paul Rothman still hold?

After the reported transaction, Paul Rothman held 773 Restricted Stock Units. This figure reflects the aggregate number of remaining units, each representing the right to receive one share of Labcorp common stock upon future vesting or settlement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/13/2026 - 01:03 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rothman Paul

(Last) (First) (Middle)

531 SOUTH SPRING STREET

(Street)

BURLINGTON NC 27215

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/11/2026		M		897	A	(1)	2,571	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	02/11/2026		M			897	(2)	(2)	Common Stock	897	$0	773(3)	D

Explanation of Responses:

1. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

2. The Restricted Stock Units vested fully on February 11, 2026.

3. This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

	/s/ Kathryn W. Kyle, Attorney-in-Fact for Paul Rothman	02/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.